Gland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has announced the closure of its trading window starting October 1, 2025, in line with SEBI's insider trading regulations. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter and half year ending September 30, 2025. During this period, insiders and designated persons are prohibited from trading in the company's shares. The date of the board meeting to approve these Q2/H1 FY26 results has not yet been announced and will be communicated later.
This is a routine compliance announcement and not material to the stock price. It signals that Q2 FY26 results are approaching, and investors should watch for the upcoming board meeting date for the earnings announcement.